Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, June 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 310 articles:
HTML format


 

Single Articles

  1. SUNDQVIST A, Moberg L, Dickman PW, Hogberg T, et al
    Time trends for incidence and net survival of cervical cancer in Sweden 1960-2014 - A nationwide population-based study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699333.
    PubMed    
    Abstract available

  2. WALLIN E, Falconer H, Carlson J, Haglund C, et al
    Objective and subjective assessment of bladder function after robot-assisted laparoscopic radical hysterectomy for early stage cervical cancer.
    J Minim Invasive Gynecol. 2022 May 30. pii: S1553-4650(22)00214.
    PubMed    
    Abstract available

  3. GULTEKIN M, Yilmaz MT, Yuce Sari S, Yildiz D, et al
    Stereotactic body radiotherapy boost in patients with cervical cancer.
    J Obstet Gynaecol. 2022 Jun 2:1-8. doi: 10.1080/01443615.2022.2081790.
    PubMed    
    Abstract available

  4. ONAL C, Gultekin M, Yavas G, Oymak E, et al
    The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy.
    J Obstet Gynaecol. 2022 Jun 2:1-7. doi: 10.1080/01443615.2022.2069484.
    PubMed    
    Abstract available

  5. DUENAS-GONZALEZ A
    Combinational therapies for the treatment of advanced cervical cancer.
    Expert Opin Pharmacother. 2022 Jun 2. doi: 10.1080/14656566.2022.2084689.
    PubMed    
    Abstract available

  6. SAMMAN E, Mkuu R, Zhang X, Scummings S, et al
    Body Mass Index and Breast and Cervical Cancer Screening.
    Womens Health Rep (New Rochelle). 2022;3:508-514.
    PubMed    
    Abstract available

  7. SU R, Jin C, Bu H, Xiang J, et al
    Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer.
    Front Oncol. 2022;12:861392.
    PubMed    
    Abstract available

  8. HE Y, Wang J, Xie S, Xue Q, et al
    Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer.
    Front Surg. 2022;9:908101.
    PubMed    
    Abstract available

  9. FERREIRA MCM, Nogueira MC, Ferreira LCM, Bustamante-Teixeira MT, et al
    [Early detection and prevention of cervical cancer: knowledge, attitudes and practices of FHS professionals].
    Cien Saude Colet. 2022;27:2291-2302.
    PubMed    
    Abstract available

  10. AZER SA, AlSaleem A, Albassam N, Khateeb R, et al
    What do university students know about cervical cancer and HPV vaccine?
    Eur Rev Med Pharmacol Sci. 2022;26:3735-3744.
    PubMed    
    Abstract available

  11. RAJAN RS, Dass SA, Tye GJ, Balakrishnan V, et al
    A short review on cervical cancer cell lines characterization and their corresponding human leukocyte antigen (HLA) type expression.
    Eur Rev Med Pharmacol Sci. 2022;26:3570-3576.
    PubMed    
    Abstract available

  12. KOBAYASHI R, Murakami N, Chiba T, Okuma K, et al
    Effect of Hyaluronate Acid Injection on Dose-Volume Parameters in Brachytherapy for Cervical Cancer.
    Adv Radiat Oncol. 2022;7:100918.
    PubMed    
    Abstract available

  13. MENG Q, Wang W, Liu X, Wang D, et al
    Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System.
    Front Oncol. 2022;12:870670.
    PubMed    
    Abstract available

  14. ORANG'O O, Tonui P, Muthoka K, Kiptoo S, et al
    A community-based approach to cervical cancer prevention in western Kenya: An AMPATH feasibility project.
    SAGE Open Med. 2022;10:20503121221102111.
    PubMed    
    Abstract available

  15. ZHOU ZW, Long HZ, Xu SG, Li FJ, et al
    Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways.
    Front Pharmacol. 2022;13:899208.
    PubMed    
    Abstract available

  16. CHUA BWB, Ma VY, Alcantar-Fernandez J, Wee HL, et al
    Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
    Int J Public Health. 2022;67:1604621.
    PubMed    


  17. MUKHERJEE A, Pednekar CB, Kolke SS, Kattimani M, et al
    Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer.
    Proteomes. 2022;10.
    PubMed    
    Abstract available

  18. ZHANG X, Chen J, Liu N, Wang Q, et al
    Camrelizumab (SHR-1210) with carboplatin and albumin-binding paclitaxel in patients with metastatic or recurrent cervical cancer: An open-label, phase 2 trial.
    J Cancer Res Ther. 2022;18:482-487.
    PubMed    
    Abstract available

  19. SU G, Chen X, Yang H
    Pantoprazole promotes the sensitivity of cervical cancer cells to cisplatin by inhibiting cisplatin-induced autophagy.
    J Cancer Res Ther. 2022;18:362-369.
    PubMed    
    Abstract available

  20. WEI J, Gao Y, Li Z, Jia H, et al
    Retraction notice to "LncRNA SNHG6 facilitates cell proliferation, migration, invasion and EMT by upregulating UCK2 and activating the Wnt/ss-catenin signaling in cervical cancer" [Bioorg. Chem. 120 (2022) 105488].
    Bioorg Chem. 2022;120:105886.
    PubMed    


  21. BEVILACQUA KG, Gottschlich A, Murchland AR, Alvarez CS, et al
    Cervical cancer knowledge and barriers and facilitators to screening among women in two rural communities in Guatemala: a qualitative study.
    BMC Womens Health. 2022;22:197.
    PubMed    
    Abstract available

  22. RENDLE KA, Ramogola-Masire D, Monare B, Ogden SN, et al
    Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study.
    BMC Womens Health. 2022;22:195.
    PubMed    
    Abstract available

  23. WU N, Zhang X, Zhu M, Fang C, et al
    ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase.
    Epigenetics. 2022 Jun 1. doi: 10.1080/15592294.2022.2080995.
    PubMed    
    Abstract available

  24. BURANRAT B, Boontha S
    The seed extract of Oroxylum indicum suppresses cell proliferation, migration and promotes apoptosis in cervical cancer cells.
    Pak J Pharm Sci. 2022;35:553-559.
    PubMed    
    Abstract available

  25. SINGINI MG, Singh E, Bradshaw D, Ramaliba T, et al
    The usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis.
    J Med Virol. 2022 May 31. doi: 10.1002/jmv.27900.
    PubMed    
    Abstract available

  26. LIU G, Yang Z, Wang C, Wang D, et al
    PM2.5 exposure and cervical cancer survival in Liaoning Province, northeastern China.
    Environ Sci Pollut Res Int. 2022 May 31. pii: 10.1007/s11356-022-20597.
    PubMed    
    Abstract available

  27. DI PAOLA V, Perillo F, Gui B, Russo L, et al
    Detection of parametrial invasion in women with uterine cervical cancer using diffusion tensor imaging at 1.5T MRI.
    Diagn Interv Imaging. 2022 May 28. pii: S2211-5684(22)00095.
    PubMed    
    Abstract available

  28. GIVENS NT, Zhao L, Zhu Z, Lequio M, et al
    Mangosteen Inhibits Growth and Survival of Cervical Cancer Cells.
    Anticancer Res. 2022;42:2903-2909.
    PubMed    
    Abstract available

  29. UNO A, Yamamoto S, Iihara H, Fujii H, et al
    Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy.
    Anticancer Res. 2022;42:3117-3123.
    PubMed    
    Abstract available

  30. CANFELL K, Smith M, Saville M, Arbyn M, et al
    HPV screening for cervical cancer is reaching maturity.
    BMJ. 2022;377:o1303.
    PubMed    


  31. REBOLJ M, Cuschieri K, Mathews CS, Pesola F, et al
    Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.
    BMJ. 2022;377:e068776.
    PubMed    
    Abstract available

  32. SHEN X, Li L, He Y, Lv X, et al
    EIF5A2 Is Involved in the Biological Process of Cervical Cancer Cells through AGR2.
    Pharmacology. 2022 May 31:1-10. doi: 10.1159/000524017.
    PubMed    
    Abstract available

  33. SHIRI AGHBASH P, Shirvaliloo M, Khalo Abass Kasho A, Alinezhad F, et al
    Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
    Int Immunopharmacol. 2022;108:108896.
    PubMed    
    Abstract available

  34. XIONG J, Sheng J, Wei Y, Sun Z, et al
    Sesamol Augments Paclitaxel-Induced Apoptosis in Human Cervical Cancer Cell Lines.
    Nutr Cancer. 2022 May 31:1-9. doi: 10.1080/01635581.2022.2079684.
    PubMed    
    Abstract available

  35. SCHARL S, Hugo C, Weidenbacher CB, Bronger H, et al
    Intracavitary brachytherapy with additional Heyman capsules in the treatment of cervical cancer.
    Arch Gynecol Obstet. 2022 May 31. pii: 10.1007/s00404-022-06602.
    PubMed    
    Abstract available

  36. SHEN W, Zhu M, Wang Q, Zhou X, et al
    DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer.
    RNA Biol. 2022;19:751-763.
    PubMed    
    Abstract available

  37. HAYEK J, Mowzoon M, Demissie S, Palileo A, et al
    Minimally invasive versus open surgery for women with stage 1A1 and stage 1A2 cervical cancer: A retrospective database cohort study.
    Ann Med Surg (Lond). 2022;77:103507.
    PubMed    
    Abstract available

  38. WANG W, Arca E, Sinha A, Hartl K, et al
    Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review.
    Prev Med Rep. 2022;28:101813.
    PubMed    
    Abstract available

  39. WEI G, Jiang P, Tang Z, Qu A, et al
    MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
    Magn Reson Imaging. 2022 May 27. pii: S0730-725X(22)00085.
    PubMed    
    Abstract available

  40. FAN H, He Y, Xiang J, Zhou J, et al
    ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy.
    Redox Biol. 2022;53:102339.
    PubMed    
    Abstract available

  41. DE OLIVEIRA NPD, de Camargo Cancela M, Martins LFL, Meira KC, et al
    Completeness of cervical cancer staging information in Brazil: A national hospital-based study.
    Cancer Epidemiol. 2022;79:102191.
    PubMed    
    Abstract available

  42. ZHANG D, Yuan Z, Hu P, Yang Y, et al
    Automatic treatment planning for cervical cancer radiation therapy using direct three-dimensional patient anatomy match.
    J Appl Clin Med Phys. 2022 May 30:e13649. doi: 10.1002/acm2.13649.
    PubMed    
    Abstract available

  43. SADIA H, Shahwani IM, Bana KFM
    Risk factors of cervical cancer and role of primary healthcare providers regarding PAP smears counseling: Case control study.
    Pak J Med Sci. 2022;38.
    PubMed    
    Abstract available

  44. GUPTA S, Purwar S, Gupta P, Halder A, et al
    Burden and Associated Genotype Patterns of High-Risk Human Papilloma Virus Infection and Cervical Cytology Abnormalities among Women in Central India.
    Infect Dis Obstet Gynecol. 2022;2022:3932110.
    PubMed    
    Abstract available

  45. SASIDHARANPILLAI S, Ravishankar N
    The Short-Term Impact Of COVID-19 Pandemic on Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2022;23:1497-1504.
    PubMed    
    Abstract available

  46. YONEMORI K, Kuboki Y, Hasegawa K, Iwata T, et al
    Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: results from the innovaTV 206 study.
    Cancer Sci. 2022 May 28. doi: 10.1111/cas.15443.
    PubMed    
    Abstract available

  47. PEREZ-BACHO EG, Beltran-Anaya FO, Arechaga-Ocampo E, Hernandez-Sotelo D, et al
    The E6 Oncoprotein of HPV16 AA-c Variant Regulates Cell Migration through the MINCR/miR-28-5p/RAP1B Axis.
    Viruses. 2022;14.
    PubMed    
    Abstract available

  48. HEIDEMAN DAM, Ostrbenk Valencak A, Doorn S, Bonde J, et al
    Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening.
    Viruses. 2022;14.
    PubMed    
    Abstract available

  49. ZAID A, Haw XR, Alkatib HH, Sasidharan S, et al
    Phytochemical Constituents and Antiproliferative Activities of Essential Oils from Four Varieties of Malaysian Zingiber officinale Roscoe against Human Cervical Cancer Cell Line.
    Plants (Basel). 2022;11.
    PubMed    
    Abstract available

  50. RIEMMA G, Schettino MT, Munno GM, Fasulo DD, et al
    Echinacea angustifolia and Echinacea purpurea Supplementation Combined with Vaginal Hyaluronic Acid to Boost the Remission of Cervical Low-Grade Squamous Intraepithelial Lesions (L-SILs): A Randomized Controlled Trial.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  51. MICCO M, Lupinelli M, Mangialardi M, Gui B, et al
    Patterns of Recurrent Disease in Cervical Cancer.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  52. KWON AY, Jeong JY, Park H, Hwang S, et al
    miR-22-3p and miR-30e-5p Are Associated with Prognosis in Cervical Squamous Cell Carcinoma.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  53. CHUANG PC, Chen PT, Wang CC, Su WH, et al
    MicroRNA-29a Manifests Multifaceted Features to Intensify Radiosensitivity, Escalate Apoptosis, and Revoke Cell Migration for Palliating Radioresistance-Enhanced Cervical Cancer Progression.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  54. LIU CH, Yang ST, Chao WT, Lin JC, et al
    Pretreatment Radiologically Enlarged Lymph Nodes as a Significant Prognostic Factor in Clinical Stage IIB Cervical Cancer: Evidence from a Taiwanese Tertiary Care Center in Reaching Consensus.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  55. HABANOVA H, Mikula P, Tvrdik T, Dedinska E, et al
    Emergency Uterine Artery Embolization Used for Managing Profuse Intra-Abdominal Bleeding and Uterine Rupture in a Patient with Advanced Cervical Cancer.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  56. PORTERO DE LA CRUZ S, Cebrino J
    Trends and Determinants in Uptake of Cervical Cancer Screening in Spain: An Analysis of National Surveys from 2017 and 2020.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  57. ZHOU Y, Rassy E, Coutte A, Achkar S, et al
    Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  58. YU S, Li X, Ma M, Yang R, et al
    The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  59. HODNELAND E, Kaliyugarasan S, Wagner-Larsen KS, Lura N, et al
    Fully Automatic Whole-Volume Tumor Segmentation in Cervical Cancer.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  60. BRUNO MT, Cassaro N, Vitale SG, Guaita A, et al
    Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women.
    Virol J. 2022;19:95.
    PubMed    
    Abstract available

  61. SHIN KE
    Epidural abscess formation after chemoradiation therapy for esophageal cancer: A case report and literature review.
    Medicine (Baltimore). 2022;101:e29426.
    PubMed    
    Abstract available

  62. SHAPIRO GK
    HPV Vaccination: An Underused Strategy for the Prevention of Cancer.
    Curr Oncol. 2022;29:3780-3792.
    PubMed    
    Abstract available

  63. MAEDA M, Hisa T, Matsuzaki S, Lee M, et al
    The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study.
    Curr Oncol. 2022;29:3770-3779.
    PubMed    
    Abstract available

  64. SANTELLA C, Tratt E, Nyamiaka J, Whiteley Tukkiapik L, et al
    Perceptions of Inuit Women and Non-Inuit Healthcare Providers on the Implementation of Human Papillomavirus Self-Sampling as an Alternative Cervical Cancer Screening Method in Nunavik, Northern Quebec.
    Qual Health Res. 2022 May 27:10497323221090805. doi: 10.1177/10497323221090805.
    PubMed    
    Abstract available

  65. VASANTHAKUMAR A, Rejeeth C, Vivek R, Ponraj T, et al
    Design of Bio-Graphene-Based Multifunctional Nanocomposites Exhibits Intracellular Drug Delivery in Cervical Cancer Treatment.
    ACS Appl Bio Mater. 2022 May 27. doi: 10.1021/acsabm.2c00280.
    PubMed    
    Abstract available

  66. MAKGOO L, Mosebi S, Mbita Z
    Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.
    Front Mol Biosci. 2022;9:875208.
    PubMed    
    Abstract available

  67. KINJO Y, Matsuura Y, Ohguri T, Aoyama Y, et al
    Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB-IIA node negative uterine cervical cancer after radical hysterectomy and trachelectomy.
    Mol Clin Oncol. 2022;16:105.
    PubMed    
    Abstract available

  68. ZHAO H, Peng Y, Lv M, Shi Y, et al
    Incidence and risk factors of perioperative venous thromboembolism in patients with cervical cancer.
    Mol Clin Oncol. 2022;16:108.
    PubMed    
    Abstract available

  69. ZHANG H, Tan S, Fang C, Zhang Q, et al
    PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer.
    Front Oncol. 2022;12:858164.
    PubMed    
    Abstract available

  70. COLERIDGE SL, Wiggans A, Nelissen E, Bethune R, et al
    Improving the uptake of cervical screening in pregnant and recently postnatal women: a quality improvement project.
    BMJ Open Qual. 2022;11.
    PubMed    
    Abstract available

  71. TEOH D, Nam G, Aase DA, Russell R, et al
    Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination.
    JAMA Netw Open. 2022;5:e2214020.
    PubMed    
    Abstract available

  72. PENG Y, Pan J, Ou F, Wang W, et al
    Fenbendazole and its synthetic analog interfere with HeLa cells' proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway.
    Chem Biol Interact. 2022;361:109983.
    PubMed    
    Abstract available

  73. ANTONIO-VEJAR V, Ortiz-Sanchez E, Rosendo-Chalma P, Patino-Morales CC, et al
    New insights into the interactions of HPV-16 E6*I and E6*II with p53 isoforms and induction of apoptosis in cancer-derived cell lines.
    Pathol Res Pract. 2022;234:153890.
    PubMed    
    Abstract available

  74. TANG L, Li C, Chen W, Zeng Y, et al
    Causal Association between Chronic Kidney Disease and Risk of 19 Site-Specific Cancers: A Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1233-1242.
    PubMed    
    Abstract available

  75. BACORRO W, Baldivia K, Dumago M, Bojador M, et al
    Phase 1/2 trial evaluating the effectiveness and safety of dose-adapted Hypofractionated pelvic radiotherapy for Advanced Cervical cancers INeligible for ChemoTherapy (HYACINCT).
    Acta Oncol. 2022;61:688-697.
    PubMed    
    Abstract available

  76. FONSECA FV, Cordeiro MVG, Pozza AC, Maestri CA, et al
    Cervical Intraepithelial Neoplasia: Analyzing the Disease Present Exclusively in the Endocervical Canal.
    Rev Bras Ginecol Obstet. 2022;44:385-390.
    PubMed    
    Abstract available

  77. PAN Y, Wei M, Gong T
    Ultrasound microbubble-mediated delivery of ANLN silencing-repressed EZH2 expression alleviates cervical cancer progression.
    Tissue Cell. 2022;77:101843.
    PubMed    
    Abstract available

  78. YU K, Zhou L
    Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy Combined with Intracavitary Posterior Radiotherapy for the Treatment of Medium-Term and Advanced Cervical Cancer: Efficacy, Safety and Prognostic Factors.
    Front Surg. 2022;9:906117.
    PubMed    
    Abstract available

  79. YADAV A, Dobe M, Paul B, Taklikar C, et al
    A cross-sectional study on assessment of perceived threat to cervical cancer using health belief model among women in a slum area of Kolkata.
    J Educ Health Promot. 2022;11:124.
    PubMed    
    Abstract available

  80. KEBEBEW T, Mosalo A, Mavhandu-Mudzusi AH
    Caregivers' satisfaction with cervical cancer care in Ethiopia.
    Support Care Cancer. 2022 Jun 8. pii: 10.1007/s00520-022-07201.
    PubMed    
    Abstract available

  81. UNGUREANU C, Socolov DG, Anton G, Morosan E, et al
    Role of ProEx C immunocytochemistry in cervical high-grade squamous intraepithelial lesions detection.
    Rom J Morphol Embryol. 2021;62:1029-1034.
    PubMed    
    Abstract available

  82. DIAMOND CJ, Laurentiev J, Yang J, Wint A, et al
    Natural Language Processing to Identify Abnormal Breast, Lung, and Cervical Cancer Screening Test Results from Unstructured Reports to Support Timely Follow-up.
    Stud Health Technol Inform. 2022;290:433-437.
    PubMed    
    Abstract available

  83. MILOSAVLJEVIC S, Yang PY, Kang H, Mullen PD, et al
    Quality Assessment of Meta-Analyses on Cervical Cancer.
    Stud Health Technol Inform. 2022;290:428-432.
    PubMed    
    Abstract available

  84. BARRERA FERRO D, Bayer S, Brailsford S, Smith H, et al
    Improving intervention design to promote cervical cancer screening among hard-to-reach women: assessing beliefs and predicting individual attendance probabilities in Bogota, Colombia.
    BMC Womens Health. 2022;22:212.
    PubMed    
    Abstract available

  85. BIZZARRI N, Loverro M, Angeles MA, Pedone Anchora L, et al
    ASO Author Reflections: Laparoscopic Ovarian Transposition for Locally Advanced Cervical Cancer-Tailoring the Treatment with the Standardization of a Surgical Procedure.
    Ann Surg Oncol. 2022 Jun 7. pii: 10.1245/s10434-022-11969.
    PubMed    


  86. DAKO-GYEKE P, Asampong E, Opoku-Mensah K, Tabong PT, et al
    Social innovations to increase health coverage: evidence from a crowdsourcing contest in Ghana.
    BMJ Open. 2022;12:e063119.
    PubMed    
    Abstract available

  87. FARIA LV, Emmerick ICM, da Silva MJS
    Effect of municipal and state regulation on access and outcomes for cervical cancer patients in Rio de Janeiro, Brazil: an interrupted time series analysis.
    J Cancer Policy. 2022 Jun 4:100339. doi: 10.1016/j.jcpo.2022.100339.
    PubMed    
    Abstract available

  88. STOCKS J, Ibrahim S, Park L, Huchko M, et al
    Mobile Phone Ownership and Use Among Women Screening for Cervical Cancer in a Community-Based Setting in Western Kenya: Observational Study.
    JMIR Public Health Surveill. 2022;8:e28885.
    PubMed    
    Abstract available

  89. WU M, Wu J, Huang L, Chen Y, et al
    Comparison of contrast-enhanced ultrasonography and magnetic resonance imaging in the evaluation of tumor size and local invasion of surgically treated cervical cancer.
    Abdom Radiol (NY). 2022 Jun 7. pii: 10.1007/s00261-022-03558.
    PubMed    
    Abstract available

  90. KAMIYA N, Matsunaga T, Miyagi E
    Two cases showing the effects of bevacizumab on recurrent cervical cancer with pleural effusion.
    Int Cancer Conf J. 2022;11:165-171.
    PubMed    
    Abstract available

  91. BUKKEMS LJH, Jurgenliemk-Schulz IM, van der Leij F, Peters M, et al
    The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis.
    Clin Transl Radiat Oncol. 2022;35:97-103.
    PubMed    
    Abstract available

  92. KONG B, Han CY, Kim SI, Patten DA, et al
    Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
    J Ovarian Res. 2022;15:70.
    PubMed    
    Abstract available

  93. HAMMERLI P, Moukam AD, Wisniak A, Sormani J, et al
    "My motivation was to save": a qualitative study exploring factors influencing motivation of community healthcare workers in a cervical cancer screening program in Dschang, Cameroon.
    Reprod Health. 2022;19:133.
    PubMed    
    Abstract available

  94. SEHNAL BOREK, Driak Daniel, Dzubakova Nipcova Monika, Slama Jiri, et al
    Current data on the efficacy of prophylactic HPV vaccination in the primary prevention of cervical lesions.
    Ceska Gynekol. 2022;87:124-130.
    PubMed    
    Abstract available

  95. CHEN F, Novak Z, Dannecker C, Mokras C, et al
    Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol.
    BMJ Open. 2022;12:e061740.
    PubMed    
    Abstract available

  96. DE LUGET CD, Blanc J, Chantalat E, Auquier P, et al
    [Database's development for prospective national collection of clinical data on cervical cancer: A Delphi survey identifying consensual variables].
    Gynecol Obstet Fertil Senol. 2022 Jun 3. pii: S2468-7189(22)00200.
    PubMed    
    Abstract available

  97. MBOINEKI JF, Wang P, Dhakal K, Getu MA, et al
    The Effect of Peer-Led Navigation Approach as a Form of Task Shifting in Promoting Cervical Cancer Screening Knowledge, Intention, and Practices Among Urban Women in Tanzania: A Randomized Controlled Trial.
    Cancer Control. 2022;29:10732748221089480.
    PubMed    
    Abstract available

  98. GHALEH HEG, Shahriary A, Izadi M, Farzanehpour M, et al
    Advances in early diagnosis of cervical cancer based on biosensors.
    Biotechnol Bioeng. 2022 Jun 3. doi: 10.1002/bit.28149.
    PubMed    
    Abstract available

  99. BRETO AL, Spieler B, Zavala-Romero O, Alhusseini M, et al
    Deep Learning for Per-Fraction Automatic Segmentation of Gross Tumor Volume (GTV) and Organs at Risk (OARs) in Adaptive Radiotherapy of Cervical Cancer.
    Front Oncol. 2022;12:854349.
    PubMed    
    Abstract available

  100. ZHANG H, Lu W, Cui H, Li Y, et al
    Assessment of Statistical Process Control Based DVH Action Levels for Systematic Multi-Leaf Collimator Errors in Cervical Cancer RapidArc Plans.
    Front Oncol. 2022;12:862635.
    PubMed    
    Abstract available

  101. ABUDOUKERIMU A, Hasimu A, Abudoukerimu A, Tuerxuntuoheti G, et al
    HIF-1alpha Regulates the Progression of Cervical Cancer by Targeting YAP/TAZ.
    J Oncol. 2022;2022:3814809.
    PubMed    
    Abstract available

  102. SIMS TT, Colbert LE, Klopp AH
    The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.
    J Immunother Precis Oncol. 2020;4:72-78.
    PubMed    
    Abstract available

  103. YAO H, Jiang X, Fu H, Yang Y, et al
    Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer.
    Front Pharmacol. 2022;13:870221.
    PubMed    
    Abstract available

  104. YANG D, Fan L, Song Z, Fang S, et al
    The KMT1A/TIMP3/PI3K/AKT circuit regulates tumor growth in cervical cancer.
    Reprod Biol. 2022;22:100644.
    PubMed    
    Abstract available

  105. BAHALL V, De Barry L, Barrow M, Ramnarace R, et al
    Metastatic gastric adenocarcinoma to the uterine cervix-a case report and review of the literature.
    World J Surg Oncol. 2022;20:177.
    PubMed    
    Abstract available

  106. WU Y, Zhang L, Bao Y, Wan B, et al
    Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/ERK/c-Myc pathway in cervical cancer cells.
    J Obstet Gynaecol. 2022 Jun 4:1-7. doi: 10.1080/01443615.2022.2062225.
    PubMed    
    Abstract available

  107. AYHAN S, Akar S, Kar I, Turan AT, et al
    Prognostic value of systemic inflammatory response markers in cervical cancer.
    J Obstet Gynaecol. 2022 Jun 4:1-9. doi: 10.1080/01443615.2022.2069482.
    PubMed    
    Abstract available

  108. ZHOU F, Chen F, Pan T, Zhu T, et al
    [Outcomes and prognosis of radical surgery in patients with stageb2 and a2 cervical squamous cell carcinoma].
    Zhonghua Fu Chan Ke Za Zhi. 2022;57:361-369.
    PubMed    
    Abstract available

  109. HE Y, Wang Y, Ji C, Liu Y, et al
    [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    Zhonghua Fu Chan Ke Za Zhi. 2022;57:352-360.
    PubMed    
    Abstract available

  110. FEDEWA SA, Star J, Bandi P, Minihan A, et al
    Changes in Cancer Screening in the US During the COVID-19 Pandemic.
    JAMA Netw Open. 2022;5:e2215490.
    PubMed    
    Abstract available

  111. HOGH LMB, Eriksen DO, Hjorth IMD, Hammer A, et al
    [HPV vaccination for women].
    Ugeskr Laeger. 2022;184.
    PubMed    
    Abstract available

  112. LAU J, Shrestha P, Shaina Ng J, Jianlin Wong G, et al
    Qualitative factors influencing breast and cervical cancer screening in women: A scoping review.
    Prev Med Rep. 2022;27:101816.
    PubMed    
    Abstract available

  113. OKUHARA T, Okada H, Goto E, Tsunezumi A, et al
    Encouragement of cervical cancer screening via an evolutionary theoretical approach: A randomized controlled study in Japan.
    Prev Med Rep. 2022;27:101818.
    PubMed    
    Abstract available

  114. O'DONOVAN B, Mooney T, Rimmer B, Fitzpatrick P, et al
    Corrigendum to "Trust and cancer screening: Effects of a screening controversy on women's perceptions of cervical cancer screening" [Prev. Med. Rep. 25 (2022) 101684].
    Prev Med Rep. 2022;27:101773.
    PubMed    
    Abstract available

  115. CONTRERAS-OCHOA CO, Bahena-Roman M, Lopez-Diaz LY, Lagunas-Martinez A, et al
    Fas and Fas ligand are highly expressed in lymphocytes from cervical intraepithelial neoplasia and cervical cancer patients: A possible role for immune escaping.
    Iran J Basic Med Sci. 2022;25:383-389.
    PubMed    
    Abstract available

  116. NIMLAMOOL W, Chansakaow S, Potikanond S, Wikan N, et al
    The Leaf Extract of Mitrephora chulabhorniana Suppresses Migration and Invasion and Induces Human Cervical Cancer Cell Apoptosis through Caspase-Dependent Pathway.
    Biomed Res Int. 2022;2022:2028082.
    PubMed    
    Abstract available

  117. WONG EL, Cheung AW, Chen Z, Wong AY, et al
    Molecular Epidemiology of Human Papillomavirus Infection Among Chinese Women With Cervical Cytological Abnormalities.
    Front Public Health. 2022;10:820517.
    PubMed    
    Abstract available

  118. ZHOU L, Gu B, Xu X, Li Y, et al
    On Imported and Domestic Human Papillomavirus Vaccines: Cognition, Attitude, and Willingness to Pay in Chinese Medical Students.
    Front Public Health. 2022;10:863748.
    PubMed    
    Abstract available

  119. LI L, Song Q, Cao D, Jiao Y, et al
    Whole-Exome Sequencing Could Distinguish Primary Pulmonary Squamous Cell Carcinoma From Lung Metastases in Individuals With Cervical Squamous Cell Carcinoma.
    Pathol Oncol Res. 2022;28:1610325.
    PubMed    
    Abstract available

  120. LLAVE CL, Uy MEV, Lam HY, Aldaba JG, et al
    The cost-effectiveness of human papillomavirus vaccination in the Philippines.
    Vaccine. 2022 May 20. pii: S0264-410X(22)00609.
    PubMed    
    Abstract available

  121. EJEGOD DM, Pedersen H, Pedersen BT, Serizawa R, et al
    Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
    Prev Med. 2022;160:107096.
    PubMed    
    Abstract available

  122. GANGOPADHYAY A
    Why cervical self-sampling can aid radiotherapy in India in the COVID-19 era.
    J Cancer Policy. 2022;32:100330.
    PubMed    


  123. BRAY F, Parkin DM
    Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.
    Lancet Oncol. 2022;23:719-728.
    PubMed    
    Abstract available

  124. SCHOTT E, Schaller K, Mons U, Ouedraogo N, et al
    [Approaches to increase HPV vaccination rate in Germany - challenges and opportunities. A qualitative study].
    Z Evid Fortbild Qual Gesundhwes. 2022;170:29-37.
    PubMed    
    Abstract available

  125. KHAIRKHAH N, Bolhassani A, Najafipour R
    Current and future direction in treatment of HPV-related cervical disease.
    J Mol Med (Berl). 2022;100:829-845.
    PubMed    
    Abstract available

  126. WOLFORD JE, Ferrigni E, Margul D, Herzog TJ, et al
    Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers.
    Curr Oncol Rep. 2022;24:889-904.
    PubMed    
    Abstract available

  127. ZHANG J, Wang L, Liu Y, Liu W, et al
    Exogenous interleukin-1 beta promotes the proliferation and migration of HeLa cells via the MEK/ERK signaling pathway.
    Mol Biol Rep. 2022;49:3765-3772.
    PubMed    
    Abstract available

  128. PANTANOWITZ L
    Improving the Pap test with artificial intelligence.
    Cancer Cytopathol. 2022;130:402-404.
    PubMed    


  129. TAO X, Chu X, Guo B, Pan Q, et al
    Scrutinizing high-risk patients from ASC-US cytology via a deep learning model.
    Cancer Cytopathol. 2022;130:407-414.
    PubMed    
    Abstract available

  130. WANG X, You L, Zhang W, Ma Y, et al
    Evaluation of 5-aminolevulinic acid-mediated photodynamic therapy on cervical low-grade squamous intraepithelial lesions with high-risk HPV infection.
    Photodiagnosis Photodyn Ther. 2022;38:102807.
    PubMed    
    Abstract available

  131. POLONIJO AN, Mahapatra D, Brown B
    "I Thought It Was Just For Teenagers": Knowledge, Attitudes, and Beliefs about HPV Vaccination Among Women Aged 27 to 45.
    Womens Health Issues. 2022;32:301-308.
    PubMed    
    Abstract available

  132. SHAH PM, Ngamasana E, Shetty V, Ganesh M, et al
    Knowledge, Attitudes and HPV Vaccine Intention Among Women in India.
    J Community Health. 2022;47:484-494.
    PubMed    
    Abstract available

  133. VINK FJ, Steenbergen RDM, Kremer WW, Lissenberg-Witte BI, et al
    Post-treatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.
    AIDS. 2022 Feb 11. pii: 00002030-900000000-96219.
    PubMed    
    Abstract available

  134. KHODADADI AB, Hansen B, Kim YI, Scarinci IC, et al
    Latinx Immigrant Mothers' Perceived Self-Efficacy and Intentions Regarding Human Papillomavirus Vaccination of Their Daughters.
    Womens Health Issues. 2022;32:293-300.
    PubMed    
    Abstract available

  135. KALAVATHY MC, Mathew A, Jagathnath Krishna KM, Saritha VN, et al
    Risk factors and prevalence of cervical squamous intraepithelial lesions among women in south India: A community-based cross-sectional study.
    Indian J Cancer. 2022;59:95-100.
    PubMed    
    Abstract available

  136. SUN D, Cao R, Han L, Yu X, et al
    Long non-coding RNA brain cytoplasmic RNA 1 induces cisplatin-resistance of cervical cancer cells by sponging microRNA-330-5p and upregulating high-mobility group box 3.
    Gynecol Obstet Invest. 2022 Jun 15. pii: 000525437. doi: 10.1159/000525437.
    PubMed    
    Abstract available

  137. ROY JK, Prakash A
    BRN3A regulates expression of genes involved in biological processes promoting HPV induced cervical cancer.
    Eur J Cancer Prev. 2021;31.
    PubMed    


  138. SILVA DS, Pinto MC, Figueiredo MAA
    Factors associated with delay in specialized treatment after diagnosis of cervical cancer in Bahia State, Brazil.
    Cad Saude Publica. 2022;38:e00022421.
    PubMed    
    Abstract available

  139. ABDELSAMIA M, Mosalem O, Gogineni V, Gullapalli K, et al
    A Rare Case of Advanced Synchronous Primary Ovarian and Cervical Cancer.
    Cureus. 2022;14:e24876.
    PubMed    
    Abstract available

  140. OKOLIE EA, Aluga D, Anjorin S, Ike FN, et al
    Addressing missed opportunities for cervical cancer screening in Nigeria: a nursing workforce approach.
    Ecancermedicalscience. 2022;16:1373.
    PubMed    
    Abstract available

  141. SHIGETA S, Shimada M, Tsuji K, Nagai T, et al
    Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group.
    Int J Clin Oncol. 2022 Jun 14. pii: 10.1007/s10147-022-02198.
    PubMed    
    Abstract available

  142. THEPHAMONGKHOL K, Korpraphong P, Muangsomboon K, Sitathanee C, et al
    Development and validation of a prognostic prediction model including the minor lymphatic pathway for distant metastases in cervical cancer patients.
    Sci Rep. 2022;12:9873.
    PubMed    
    Abstract available

  143. GAPARE CR, El-Zein M, Patel H, Tope P, et al
    Ecological analysis of correlates of cervical cancer morbidity and mortality in Sub-Saharan Africa.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 14. pii: 704893.
    PubMed    
    Abstract available

  144. ENYAN NIE, Davies AE, Opoku-Danso R, Annor F, et al
    Correlates of cervical cancer screening participation, intention and self-efficacy among Muslim women in southern Ghana.
    BMC Womens Health. 2022;22:225.
    PubMed    
    Abstract available

  145. ALTUNKUREK SZ, Mohamed SH, Sahin E, Yilmaz S, et al
    Knowledge and attitudes of healthcare professionals working in a training and research hospital on early diagnosis of cervical cancer (a Somalia example): cross-sectional study.
    BMC Womens Health. 2022;22:228.
    PubMed    
    Abstract available

  146. ILIC I, Babic G, Dimitrijevic A, Sipetic Grujicic S, et al
    Predictors of depressive symptoms before and after diagnostic procedures in women with abnormal Pap smear attending cervical cancer screening programme in Serbia.
    Eur J Cancer Care (Engl). 2022 Jun 13:e13634. doi: 10.1111/ecc.13634.
    PubMed    
    Abstract available

  147. FRACASSO PM, Duska LR, Thaker PH, Gao F, et al
    An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer.
    Am J Clin Oncol. 2022 Jun 7. pii: 00000421-990000000-00021.
    PubMed    
    Abstract available

  148. KAVUMA A, Luutu I, Kibudde S, Kanyike D, et al
    A Retrospective Analysis of the Impact of HIV Infection on Outcomes of Locally Advanced Cervical Cancers Treated With Either Conventional or Hypofractionated Radiotherapy: The Uganda Experience.
    JCO Glob Oncol. 2022;8:e2100360.
    PubMed    
    Abstract available

  149. DUARTE MBO, Argenton JLP, Carvalheira JBC
    Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in Sao Paulo, Brazil: An Interrupted Time Series Analysis.
    JCO Glob Oncol. 2022;8:e2100371.
    PubMed    
    Abstract available

  150. TANGKANANAN A, Thongkhao P, Janmunee N, Hanprasertpong J, et al
    Impact of chemotherapy cycles on oncological outcomes in elders with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    J Med Imaging Radiat Oncol. 2022 Jun 13. doi: 10.1111/1754-9485.13443.
    PubMed    
    Abstract available

  151. JIANG Y, Song B, Chen Z
    Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
    Comput Math Methods Med. 2022;2022:5936773.
    PubMed    
    Abstract available

  152. ZHANG H, Fang C, Feng Z, Xia T, et al
    The Role of LncRNAs in the Regulation of Radiotherapy Sensitivity in Cervical Cancer.
    Front Oncol. 2022;12:896840.
    PubMed    
    Abstract available

  153. ZUNIGA MARTINEZ ML, Lopez Mendoza CM, Tenorio Salazar J, Garcia Carranca AM, et al
    Establishment, authenticity, and characterization of cervical cancer cell lines.
    Mol Cell Oncol. 2022;9:2078628.
    PubMed    
    Abstract available

  154. GUO C, Du H, Qu X, Duan X, et al
    Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST.
    Front Public Health. 2022;10:840879.
    PubMed    
    Abstract available

  155. ZHAO S, Chen H, Zhao FH
    [Global guidelines for cervical cancer and precancerous lesions treatment: a systematic review].
    Zhonghua Yi Xue Za Zhi. 2022;102:1666-1676.
    PubMed    
    Abstract available

  156. ZHANG Y, Du H, Xiao A, Zhang W, et al
    Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials.
    Infect Agent Cancer. 2022;17:27.
    PubMed    
    Abstract available

  157. BAIOCCHI G, Tsunoda AT, Guitmann G, Vieira MA, et al
    Brazilian Society of Surgical Oncology consensus on fertility-sparing surgery for cervical cancer.
    J Surg Oncol. 2022;126:37-47.
    PubMed    
    Abstract available

  158. MIHRETIE GN, Liyeh TM, Ayele AD, Belay HG, et al
    Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
    Reprod Health. 2022;19:136.
    PubMed    
    Abstract available

  159. LIANG Y, Wang W, Zhu X, Yu M, et al
    Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer.
    Sci Rep. 2022;12:9619.
    PubMed    
    Abstract available

  160. THEPHAMONGKHOL K, Korpraphong P, Muangsomboon K, Sitathanee C, et al
    Evaluation and external validation of minor lymphatic pelvic pathway for distant metastases in cervical cancer patients treated with concurrent chemoradiotherapy.
    Curr Probl Cancer. 2022;46:100876.
    PubMed    
    Abstract available

  161. SHARIF YH
    Clinical correlation of cervical cancer screening using Pap smear test.
    J Popul Ther Clin Pharmacol. 2022;29:e1-e8.
    PubMed    
    Abstract available

  162. HU Z, Sun Y, Ma Y, Chen K, et al
    Examining Primary Care Physicians' Intention to Perform Cervical Cancer Screening Services Using a Theory of Planned Behavior: A Structural Equation Modeling Approach.
    Front Public Health. 2022;10:893673.
    PubMed    
    Abstract available

  163. ZOU J, He Y, Chen H, Wang P, et al
    A Clinicopathologic Analysis of Decidual Polyps: A Potentially Problematic Diagnosis.
    Int J Clin Pract. 2022;2022:2200790.
    PubMed    
    Abstract available

  164. AL MUDAWI N, Alazeb A
    A Model for Predicting Cervical Cancer Using Machine Learning Algorithms.
    Sensors (Basel). 2022;22.
    PubMed    
    Abstract available

  165. DUDEA-SIMON M, Mihu D, Pop LA, Ciortea R, et al
    Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  166. TRYBUS E, Krol T, Trybus W
    The Multidirectional Effect of Azelastine Hydrochloride on Cervical Cancer Cells.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  167. VOIDAZAN TS, Budianu MA, Rozsnyai FF, Kovacs Z, et al
    Assessing the Level of Knowledge, Beliefs and Acceptance of HPV Vaccine: A Cross-Sectional Study in Romania.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  168. ZHANG M, Sit JWH, Chan DNS, Akingbade O, et al
    Educational Interventions to Promote Cervical Cancer Screening among Rural Populations: A Systematic Review.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  169. KIM J, Paik Y, Park S
    Cancer Screening Program Delivered by Community Health Workers for Chinese Married Immigrant Women in Korea.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  170. PAGANO AP, Ford KL, Porter Starr KN, Kiss N, et al
    Energy Metabolism in Gynecological Cancers: A Scoping Review.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  171. ALFARO K, Soler M, Maza M, Flores M, et al
    Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  172. WANG C, Shao S, Deng L, Wang S, et al
    Retraction Note to: LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway.
    Cancer Cell Int. 2022;22:210.
    PubMed    


  173. KUMAR A, Sahu U, Kumari P, Dixit A, et al
    Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer.
    Sci Rep. 2022;12:9521.
    PubMed    
    Abstract available

  174. ANDRALOJC KM, Elmelik D, Rasing M, Pater B, et al
    Targeted RNA next generation sequencing analysis of cervical smears can predict the presence of hrHPV-induced cervical lesions.
    BMC Med. 2022;20:206.
    PubMed    
    Abstract available

  175. INTURRISI F, Berkhof J
    Pricing of HPV tests in Italian tender-based settings.
    J Med Econ. 2022;25:762-768.
    PubMed    
    Abstract available

  176. LEHTINEN M, Gray P, Louvanto K, Vanska S, et al
    In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers.
    Expert Rev Vaccines. 2022;21:735-738.
    PubMed    


  177. ALI RF, Arif Siddiqi D, Mirza A, Naz N, et al
    Adolescent girls' recommendations for the design of a human papillomavirus vaccination program in Sindh, Pakistan: a qualitative study.
    Hum Vaccin Immunother. 2022;18:2045856.
    PubMed    
    Abstract available

  178. YANG J, Yeasman F, Kliewer G, Nation J, et al
    Evidence to Support Change of Clinical Pathway Following Colposcopy Treatment for Cervical Intraepithelial Neoplasia in Canada.
    J Obstet Gynaecol Can. 2022;44:650-657.
    PubMed    
    Abstract available

  179. MIX J, Saraiya M, Hallowell BD, Befano B, et al
    Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530292. doi: 10.1093.
    PubMed    
    Abstract available

  180. ALMEIDA G, Sainz JE, Fonseca R, Chaves N, et al
    Preventing Uterine Cervix Cancer: The Clinical Meaning of Atypical Glandular Cells.
    Rev Bras Ginecol Obstet. 2022;44:483-488.
    PubMed    
    Abstract available

  181. ALIMARDANI A, Dastmalchi N, Rahimi H, Safaralizadeh R, et al
    Designing a Sequence-Based Method for Identifying 14 High-Risk Carcinogenic HPV Types in Multiple Infections.
    Infect Disord Drug Targets. 2022;22:e270122200585.
    PubMed    
    Abstract available

  182. GREEN HM, Counsell N, Ward A, McCormack M, et al
    Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma - a Role in Patients with Para-aortic Lymph Node Involvement? A 10-year Institutional Experience.
    Clin Oncol (R Coll Radiol). 2022;34:e281-e290.
    PubMed    
    Abstract available

  183. NAKANISHI K, Okazaki S, Ichikawa G, Suzuki S, et al
    Allergy testing for Cremophor in a patient with cervical cancer with infusion reactions to paclitaxel and docetaxel.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  184. OLUBODUN T, Balogun MR, Olowoselu OI, Emina VA, et al
    Cervical Cancer Knowledge, Risk Factors and Screening Practices among Women Residing in Urban Slums of Lagos, Southwest, Nigeria.
    West Afr J Med. 2022;39:595-602.
    PubMed    
    Abstract available

  185. UMEDA-MIYARA K, Miyara M, Sanoh S, Kotake Y, et al
    Trehalose decreases mRNA and protein expressions of c-Jun and JunB in human cervical cancer HeLa cells.
    J Biochem. 2022 Jun 24. pii: 6617208. doi: 10.1093.
    PubMed    
    Abstract available

  186. YU L, Chen X, Liu X, Fei L, et al
    Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study.
    Front Oncol. 2022;12:915418.
    PubMed    
    Abstract available

  187. RAVEGNINI G, Gorini F, Dondi G, Tesei M, et al
    Emerging Role of MicroRNAs in the Therapeutic Response in Cervical Cancer: A Systematic Review.
    Front Oncol. 2022;12:847974.
    PubMed    
    Abstract available

  188. XU Z, Yang L, Liu Q, Yu H, et al
    Machine Learning of Dose-Volume Histogram Parameters Predicting Overall Survival in Patients with Cervical Cancer Treated with Definitive Radiotherapy.
    J Oncol. 2022;2022:2643376.
    PubMed    
    Abstract available

  189. ABJAUDE W, Prati B, Munford V, Montenegro A, et al
    ATM Pathway Is Essential for HPV-Positive Human Cervical Cancer-Derived Cell Lines Viability and Proliferation.
    Pathogens. 2022;11.
    PubMed    
    Abstract available

  190. PONIEWIERZA P, Panek G
    Cervical Cancer Prevention in the Era of the COVID-19 Pandemic.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  191. DI DONNA MC, Giallombardo V, Lo Balbo G, Cucinella G, et al
    Conventional Laparoscopy versus Robotic-Assisted Aortic Lymph-Nodal Staging for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  192. D'ORIA O, Corrado G, Lagana AS, Chiantera V, et al
    New Advances in Cervical Cancer: From Bench to Bedside.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  193. MOUDATSOU M, Vouyiouka P, Karagianni-Hatziskou E, Rovithis M, et al
    Knowledge and Use of Cervical Cancer Prevention Services among Social Work and Nursing University Students.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  194. MACIOS A, Nowakowski A
    False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  195. POPESCU A, Pantea S, Radu D, Gluhovschi A, et al
    The Impact of SARS-CoV-2 Pandemic on Patients Undergoing Radiation Therapy for Advanced Cervical Cancer at a Romanian Academic Center: A Four-Year Retrospective Analysis.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  196. MIYAMOTO S, Tanaka T, Hirosuna K, Nishie R, et al
    Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  197. BENTAHILA R, Rassy E, Achkar S, Sacino F, et al
    Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  198. BOON SS, Luk HY, Xiao C, Chen Z, et al
    Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  199. GOMES D, Yaduvanshi S, Silvestre S, Duarte AP, et al
    Taxifolin and Lucidin as Potential E6 Protein Inhibitors: p53 Function Re-Establishment and Apoptosis Induction in Cervical Cancer Cells.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  200. AI W, Wu C, Jia L, Xiao X, et al
    Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer.
    Microbiol Spectr. 2022 Jun 23:e0140122. doi: 10.1128/spectrum.01401.
    PubMed    
    Abstract available

  201. LESACK A, Smith LW, Racey CS, Gondara L, et al
    Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results.
    Curr Oncol. 2022;29:3860-3869.
    PubMed    
    Abstract available

  202. HABTEMARIAM LW, Zewde ET, Simegn GL
    Cervix Type and Cervical Cancer Classification System Using Deep Learning Techniques.
    Med Devices (Auckl). 2022;15:163-176.
    PubMed    
    Abstract available

  203. MUSUKA G, Mukandavire Z, Murewanhema G, Cuadros D, et al
    HIV status, knowledge and prevention of cervical cancer amongst adolescent girls and women: a secondary data analysis.
    Pan Afr Med J. 2022;41:262.
    PubMed    
    Abstract available

  204. ANBARI K, Hosieni A, Ghanadi P
    Retraction: Evaluation of Predictive Factors for and Barriers to Cervical Cancer Screening in Women Referring to Comprehensive Health Centers in Khorramabad during 2020.
    Maedica (Bucur). 2022;17:243.
    PubMed    


  205. SHAO X, Yang X, Liu Y, Song Q, et al
    Genetic polymorphisms in DNA repair genes and their association with risk of cervical cancer: A systematic review and meta-analysis.
    J Obstet Gynaecol Res. 2022 Jun 22. doi: 10.1111/jog.15325.
    PubMed    
    Abstract available

  206. CUI L, Yu T, Kan Y, Dong Y, et al
    Multi-parametric MRI-based peritumoral radiomics on prediction of lymph-vascular space invasion in early-stage cervical cancer.
    Diagn Interv Radiol. 2022 Jun 22. doi: 10.5152/dir.2022.20657.
    PubMed    
    Abstract available

  207. CHEKIN N, Ayatollahi H, Karimi Zarchi M
    A Clinical Decision Support System for Assessing the Risk of Cervical Cancer: Development and Evaluation Study.
    JMIR Med Inform. 2022;10:e34753.
    PubMed    
    Abstract available

  208. SHINDE S, Kalbhor M, Wajire P
    DeepCyto: a hybrid framework for cervical cancer classification by using deep feature fusion of cytology images.
    Math Biosci Eng. 2022;19:6415-6434.
    PubMed    
    Abstract available

  209. GUO F, Kong WN, Li DW, Zhao G, et al
    Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma.
    Technol Cancer Res Treat. 2022;21:15330338221106530.
    PubMed    
    Abstract available

  210. JIANG H, Huang G, Zhao N, Zhang T, et al
    Retraction Note: Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p.
    J Exp Clin Cancer Res. 2022;41:207.
    PubMed    


  211. LIU L, Wang A, Liu X, Han S, et al
    Blocking TIGIT/CD155 signalling reverses CD8(+) T cell exhaustion and enhances the antitumor activity in cervical cancer.
    J Transl Med. 2022;20:280.
    PubMed    
    Abstract available

  212. GUAN HM, Li WQ, Liu J, Zhou JY, et al
    LncRNA HIF1A-AS2 modulated by HPV16 E6 regulates apoptosis of cervical cancer cells via P53/caspase9/caspase3 axis.
    Cell Signal. 2022 Jun 18:110390. doi: 10.1016/j.cellsig.2022.110390.
    PubMed    
    Abstract available

  213. BU Y, Li Q, Liang X, Gao Q, et al
    Ultrasound-targeted microbubble destruction-mediated miR-1228 downregulation suppresses tumor proliferation, migration, and invasion of cervical cancer cells.
    Gynecol Obstet Invest. 2022 Jun 21. pii: 000525594. doi: 10.1159/000525594.
    PubMed    
    Abstract available

  214. TAGHAVI K, Lamb J, MacNab H, Peddie D, et al
    Patient choice may improve adherence to follow-up in cervical screening: a randomised-control trial.
    N Z Med J. 2022;135:146-156.
    PubMed    
    Abstract available

  215. HUANG H, Nie C, Liu XF, Song B, et al
    Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer.
    J Clin Invest. 2022 Jun 21. pii: 157726. doi: 10.1172/JCI157726.
    PubMed    
    Abstract available


  216. Statement of Retraction: Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.
    Cell Cycle. 2022 Jun 21:1. doi: 10.1080/15384101.2022.2080980.
    PubMed    


  217. ZHANG W, Lin Y
    Modified method of cervical conization with hybrid use of a cold knife and an electric knife for high-grade squamous intraepithelial lesions.
    J Int Med Res. 2022;50:3000605221106414.
    PubMed    
    Abstract available

  218. MURAKAMI N, Okuma K, Kato T, Igaki H, et al
    Now is it time to implement spacers in cervical cancer brachytherapy?
    J Radiat Res. 2022 Jun 20. pii: 6611801. doi: 10.1093.
    PubMed    
    Abstract available

  219. LEETANAPORN K, Hanprasertpong J
    Predictive Value of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients.
    Cancer Manag Res. 2022;14:1961-1972.
    PubMed    
    Abstract available

  220. MARIE TEBEU P, Saint Saba Antaon J, Adjeba M, Pikop F, et al

    Sante Publique. 2021;32:489-496.
    PubMed    
    Abstract available

  221. ANTAON JS, Essi MJ, Ngo Um Meka E, Mawamba YN, et al

    Sante Publique. 2021;33:579-589.
    PubMed    
    Abstract available

  222. MIDAKSA M, Destaw A, Addissie A, Kantelhardt EJ, et al
    Women's sexual autonomy as a determinant of cervical cancer screening uptake in Addis Ababa, Ethiopia: a case-control study.
    BMC Womens Health. 2022;22:236.
    PubMed    
    Abstract available

  223. LURA N, Wagner-Larsen KS, Forsse D, Trovik J, et al
    What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?
    Insights Imaging. 2022;13:105.
    PubMed    
    Abstract available

  224. KAUR A, Sharma Y, Kumar A, Ghosh MP, et al
    In-vitro antiproliferative efficacy of Abrus precatorius seed extracts on cervical carcinoma.
    Sci Rep. 2022;12:10226.
    PubMed    
    Abstract available

  225. RUANLA J, Muangwong P, Kittidachanan K, Tippanya D, et al
    The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT.
    Brachytherapy. 2022 Jun 14. pii: S1538-4721(22)00081.
    PubMed    
    Abstract available

  226. JIANYI D, Haili G, Bo Y, Meiqin Y, et al
    Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer.
    Cancer Immunol Immunother. 2022 Jun 20. pii: 10.1007/s00262-022-03226.
    PubMed    
    Abstract available

  227. JACOBSEN MC, Beriwal S, Dyer BA, Klopp AH, et al
    Contemporary image-guided cervical cancer brachytherapy: Consensus imaging recommendations from the Society of Abdominal Radiology and the American Brachytherapy Society.
    Brachytherapy. 2022 Jun 17. pii: S1538-4721(22)00073.
    PubMed    
    Abstract available

  228. LEE JE, Chung Y, Rhee S, Kim TH, et al
    Untold story of human cervical cancers - HPV-negative cervical cancer.
    BMB Rep. 2022 Jun 21. pii: 5594.
    PubMed    
    Abstract available

  229. YUAN L, Zhang C, Li J, Liao Y, et al
    Profiling and integrated analysis of differentially expressed circRNAs in cervical cancer.
    Genomics. 2022 Jun 17:110418. doi: 10.1016/j.ygeno.2022.110418.
    PubMed    
    Abstract available

  230. BHOORA S, Pillay TS, Punchoo R
    Cholecalciferol induces apoptosis via autocrine metabolism in epidermoid cervical cancer cells.
    Biochem Cell Biol. 2022 Jun 20. doi: 10.1139/bcb-2022-0049.
    PubMed    
    Abstract available

  231. BAETEN IGT, Hoogendam JP, Braat AJAT, Zweemer RP, et al
    Feasibility of a drop-in gamma-probe for radioguided sentinel lymph detection in early-stage cervical cancer.
    EJNMMI Res. 2022;12:36.
    PubMed    
    Abstract available

  232. ZHONG F, Yu T, Ma X, Wang S, et al
    Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women.
    Dis Markers. 2022;2022:8130373.
    PubMed    
    Abstract available

  233. ZHANG X, Zhang T, Liu B, Zhang Y, et al
    Effects of Biomimetic Micropatterned Surfaces on the Adhesion and Morphology of Cervical Cancer Cells.
    ACS Omega. 2022;7:19913-19919.
    PubMed    
    Abstract available

  234. LI D, Wang D, Feng S, Chen Q, et al
    Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer.
    Oncol Lett. 2022;24:239.
    PubMed    
    Abstract available

  235. WANG G, Lu Y, Di S, Xie M, et al
    miR-99a-5p inhibits glycolysis and induces cell apoptosis in cervical cancer by targeting RRAGD.
    Oncol Lett. 2022;24:228.
    PubMed    
    Abstract available

  236. LU L, Ji S, Jiang J, Yan Y, et al
    Body Weight Is a Valid Predictor of the Long-Term Prognosis of Cervical Cancer.
    Comput Math Methods Med. 2022;2022:5613350.
    PubMed    
    Abstract available

  237. LIU J, Wang J, Deng Z, Liu S, et al
    Differences in the Impact of Heart Rate Variability on the Surgical Approach in Patients With Early Cervical Cancer: Laparoscopic versus Open Surgery.
    Front Oncol. 2022;12:804242.
    PubMed    
    Abstract available

  238. CHEN A, Chen F, Li X, Zhang Y, et al
    A Feasibility Study of Deep Learning-Based Auto-Segmentation Directly Used in VMAT Planning Design and Optimization for Cervical Cancer.
    Front Oncol. 2022;12:908903.
    PubMed    
    Abstract available

  239. WEI E, Reisinger A, Li J, French LE, et al
    Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models.
    Front Oncol. 2022;12:860900.
    PubMed    
    Abstract available

  240. THARAVICHITKUL E, Jia-Mahasap B, Muangwong P, Chakrabandhu S, et al
    Survival outcome of cervical cancer patients treated by image-guided brachytherapy: a 'real world' single center experience in Thailand from 2008 to 2018.
    J Radiat Res. 2022 Jun 19. pii: 6611485. doi: 10.1093.
    PubMed    
    Abstract available

  241. HUANG SM, Li SB, Deng HT, Jiang QQ, et al
    [Preparation and effect against cervical cancer invasion in vitro of harmine-loaded photosensitive liposomes].
    Zhongguo Zhong Yao Za Zhi. 2022;47:2643-2651.
    PubMed    
    Abstract available

  242. CASKEY R
    HPV vaccination associated with decreased cervical cancer incidence and mortality.
    J Pediatr. 2022;245:246-249.
    PubMed    


  243. PATRA D, Pal A, Nath S, Kundu R, et al
    Insights into the transformation of VO(2+) motif to VO(3+), V2O3(4+) and VO2(+) motifs and their interconversion along with a detailed mechanistic study of their anti-cancer activity in SiHa cervical cancer cells.
    J Inorg Biochem. 2022;234:111900.
    PubMed    
    Abstract available

  244. PAKEN J, Govender CD, Pillay M, Sewram V, et al
    Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting.
    BMC Health Serv Res. 2022;22:791.
    PubMed    
    Abstract available

  245. HE Z, Bian C, Xie C
    Fertility-sparing surgery in early-stage cervical cancer: laparoscopic versus abdominal radical trachelectomy.
    BMC Womens Health. 2022;22:241.
    PubMed    
    Abstract available

  246. SHI Q, Ma Y, Zhang X, Yin C, et al
    Circ_0060551 promotes the migration and invasion of cervical cancer by Up-regulating TPD52.
    Am J Reprod Immunol. 2022 Jun 18. doi: 10.1111/aji.13586.
    PubMed    
    Abstract available

  247. LI W, Li F, Zhang Y, Ren H, et al
    X-Linked Inhibitor of Apoptosis Protein (XIAP)-Loaded Magnetic Mesoporous Silica Nanoparticles Incorporated with miR-233 to Improve Radio Sensitization of Cervical Cancer Cells and Promote Apoptosis.
    J Biomed Nanotechnol. 2022;18:747-753.
    PubMed    
    Abstract available

  248. STOLNICU S, Soslow RA
    Squamous and Glandular Epithelial Tumors of the Cervix: A Pragmatical Review Emphasizing Emerging Issues in Classification, Diagnosis, and Staging.
    Surg Pathol Clin. 2022;15:369-388.
    PubMed    
    Abstract available

  249. JI X, Chu G, Chen Y, Jiao J, et al
    Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer.
    Arch Gynecol Obstet. 2022 Jun 17. pii: 10.1007/s00404-022-06642.
    PubMed    
    Abstract available

  250. DA SILVA RLM, da Silva TTM, Pessoa RL, Sarmento ACA, et al
    Use of ginger to control nausea and vomiting caused by chemotherapy in patients with cervical cancer undergoing treatment: An experiment.
    Medicine (Baltimore). 2022;101:e29403.
    PubMed    
    Abstract available

  251. JAMSHED B, Javed M, Zaki S, Khalid H, et al
    Challenges in screening of sexually transmitted viral infections of the female genital tract: Where do we stand? - A scoping review.
    J Pak Med Assoc. 2022;72:940-946.
    PubMed    
    Abstract available

  252. RANGEL JB, Giglio AG, Cardozo CL, Bergmann A, et al
    Incidence and risk factors for the development of cerebral metastasis in cervical cancer patients.
    J Gynecol Oncol. 2022 Jun 8. pii: 33.e58. doi: 10.3802/jgo.2022.
    PubMed    
    Abstract available

  253. HUANG W, Sun S, Yu Z, Lu S, et al
    Chronic Cervicitis and Cervical Cancer Detection Based on Deep Learning of Colposcopy Images Toward Translational Pharmacology.
    Front Pharmacol. 2022;13:911962.
    PubMed    
    Abstract available

  254. LAMMINMAKI M, Leivonen A, Sarkeala T, Virtanen A, et al
    Health inequalities among Russian-born immigrant women in Finland: Longitudinal analysis on cervical cancer incidence and participation in screening.
    J Migr Health. 2022;6:100117.
    PubMed    
    Abstract available

  255. CHETRY M, Song Y, Pan C, Li R, et al
    Erratum: Effects of Galectin-1 on Biological Behavior in Cervical Cancer: Erratum.
    J Cancer. 2022;13:2415-2417.
    PubMed    
    Abstract available

  256. KEFALE B, Engidaw MT, Tesfa D, Molla M, et al
    Management Practice and Drug Related Problems and Its Contributing Factors Among Cervical Cancer Patients at Oncologic Center in Ethiopia: A Hospital-Based Retrospective Study.
    Ther Clin Risk Manag. 2022;18:643-655.
    PubMed    
    Abstract available

  257. BORGES P
    Estimating the turning point of the log-logistic hazard function in the presence of long-term survivors with an application for uterine cervical cancer data.
    J Appl Stat. 2020;48:203-213.
    PubMed    
    Abstract available

  258. AOKI Y, Kanao H, Fusegi A, Omi M, et al
    Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer.
    Int J Clin Oncol. 2022 Jun 15. pii: 10.1007/s10147-022-02197.
    PubMed    
    Abstract available

  259. DSOUZA JP, Broucke SVD, Pattanshetty S, Dhoore W, et al
    A comparison of behavioural models explaining cervical cancer screening uptake.
    BMC Womens Health. 2022;22:235.
    PubMed    
    Abstract available

  260. ARGAW M, Embiale A, Amare B
    Knowledge, and practice of cervical cancer prevention and associated factors among commercial sex workers in Shashemene Town, West Arsi, Oromia Region, Ethiopia.
    BMC Womens Health. 2022;22:233.
    PubMed    
    Abstract available

  261. ARBYN M, Simon M, de Sanjose S, Clarke MA, et al
    Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
    Lancet Oncol. 2022 Jun 13. pii: S1470-2045(22)00294.
    PubMed    
    Abstract available

  262. ALIMENA S, Davis J, Fichorova RN, Feldman S, et al
    The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer.
    Curr Probl Cancer. 2022;46:100877.
    PubMed    
    Abstract available

  263. GRIFFIN-MATHIEU G, Haward B, Tatar O, Zhu P, et al
    Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational Study.
    JMIR Res Protoc. 2022;11:e38917.
    PubMed    
    Abstract available

  264. YANG S, Wang L, Gu L, Wang Z, et al
    Mesenchymal stem cell-derived extracellular vesicles alleviate cervical cancer by delivering miR-331-3p to reduce LIMS2 methylation in tumor cells.
    Hum Mol Genet. 2022 Jun 16. pii: 6607931. doi: 10.1093.
    PubMed    
    Abstract available

  265. PRATAP PD, Raza ST, Zaidi G, Kunwar S, et al
    Genetic Variants in Interleukin-10 Gene Association with Susceptibility and Cervical Cancer Development: A Case Control Study.
    Glob Med Genet. 2022;9:129-140.
    PubMed    
    Abstract available

  266. BAI C, Zhang M, Zhang Y, He Y, et al
    Gamma-Glutamyltransferase Activity (GGT) Is a Long-Sought Biomarker of Redox Status in Blood Circulation: A Retrospective Clinical Study of 44 Types of Human Diseases.
    Oxid Med Cell Longev. 2022;2022:8494076.
    PubMed    
    Abstract available

  267. LIU C, Gao ZW, Wang X, Lin F, et al
    CD73 promotes cervical cancer growth via EGFR/AKT1 pathway.
    Transl Cancer Res. 2022;11:1089-1098.
    PubMed    
    Abstract available

  268. GUO S, Liu L, Li Y, Shi H, et al
    Correlation between nm23-H_1 expression and transvaginal color Doppler ultrasound performance after radiotherapy for cervical cancer.
    Transl Cancer Res. 2022;11:1354-1361.
    PubMed    
    Abstract available

  269. ZHU B, Wu Y, Huang J, He D, et al
    Massive prolapsed cervical lumps in cervical cancer treated with three-dimensional implant brachytherapy: a case report.
    Transl Cancer Res. 2022;11:1440-1444.
    PubMed    
    Abstract available

  270. KANGETHE JM, Monroe-Wise A, Muiruri PN, Komu JG, et al
    Utilisation of cervical cancer screening among women living with HIV at Kenya's national referral hospital.
    South Afr J HIV Med. 2022;23:1353.
    PubMed    
    Abstract available

  271. CARAMUJO C, Reis SN, Marques RV, Sousa G, et al
    Cervical carcinosarcoma: approach of a rare tumour in a rare location.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  272. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed    
    Abstract available

  273. ILARDO C, Marguerettaz M, Breton A, Azzoug T, et al
    Performance and pre-analytical stability of self-collected samples versus clinician cervical samples for the detection of HPV16, HPV18 and a pool of 12 other HPV types on the Roche Cobas 8800 System.
    New Microbiol. 2022;45:111-114.
    PubMed    
    Abstract available

  274. ZHANG M, Liu X, Mao Y, He Y, et al
    Oxygen-Generating Hydrogels Overcome Tumor Hypoxia to Enhance Photodynamic/Gas Synergistic Therapy.
    ACS Appl Mater Interfaces. 2022;14:27551-27563.
    PubMed    
    Abstract available

  275. FAN Y, Ma H, Fu Y, Liang X, et al
    Colposcopic multimodal fusion for the classification of cervical lesions.
    Phys Med Biol. 2022;67.
    PubMed    
    Abstract available

  276. GUI B, Lupinelli M, Russo L, Micco M, et al
    MRI in uterine cancers with uncertain origin: Endometrial or cervical? Radiological point of view with review of the literature.
    Eur J Radiol. 2022;153:110357.
    PubMed    
    Abstract available

  277. KUMARI S, Bhor VM
    A literature review on correlation between HPV coinfection with C. trachomatis and cervical neoplasia - coinfection mediated cellular transformation.
    Microb Pathog. 2022;168:105587.
    PubMed    
    Abstract available

  278. TUERXUN G, Abulimiti T, Abudurexiti G, Abuduxikuer G, et al
    Over-expression of EPB41L3 promotes apoptosis of human cervical carcinoma cells through PI3K/AKT signaling.
    Acta Biochim Pol. 2022;69:283-289.
    PubMed    
    Abstract available

  279. ZHU H, Yan Y, Liu Y, Meng L, et al
    The Impact of Minimally Invasive Surgery on Treating Patients with Early Cervical Adenocarcinoma.
    J Invest Surg. 2022;35:1593-1601.
    PubMed    
    Abstract available

  280. NAKISIGE C, Adams SV, Namirembe C, Okoche L, et al
    Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living with HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2022 Feb 21. pii: 00126334-900000000-95685.
    PubMed    
    Abstract available

  281. REBOLJ M, Mathews CS, Pesola F, Cuschieri K, et al
    Age-specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilot.
    BJOG. 2022;129:1278-1288.
    PubMed    
    Abstract available

  282. CRUICKSHANK M
    The Swedescore: Does structured image scoring improve colposcopy performance?
    BJOG. 2022;129:1268.
    PubMed    


  283. ALFONZO E, Holmberg E, Milsom I, Strander B, et al
    Colposcopic assessment by Swedescore, evaluation of effectiveness in the Swedish screening programme: a cross-sectional study.
    BJOG. 2022;129:1261-1267.
    PubMed    
    Abstract available

  284. YU C, Heidari Majd M, Shiri F, Shahraki S, et al
    The role of folic acid in inducing of apoptosis by zinc(II) complex in ovary and cervix cancer cells.
    Mol Divers. 2022;26:1545-1555.
    PubMed    
    Abstract available

  285. LU B, Shi H, Shao Y, Xu J, et al
    Ovarian Metastasis by Gastric-type Endocervical Adenocarcinoma: A Clinicopathologic Description of 12 Cases.
    Int J Gynecol Pathol. 2022;41:356-365.
    PubMed    
    Abstract available

  286. FAN W, Yu M, Wang X, Xie W, et al
    Non-homologous dsODN increases the mutagenic effects of CRISPR-Cas9 to disrupt oncogene E7 in HPV positive cells.
    Cancer Gene Ther. 2022;29:758-769.
    PubMed    
    Abstract available

  287. AMBALI RT, John-Akinola YO, Oluwasanu MM
    Indepth Interviews' on Acceptability and Concerns for Human Papilloma Virus Vaccine Uptake among Mothers of Adolescent Girls in Community Settings in Ibadan, Nigeria.
    J Cancer Educ. 2022;37:748-754.
    PubMed    
    Abstract available

  288. HAMMER A, Blaakaer J, de Koning MNC, Steiniche T, et al
    Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia.
    Acta Obstet Gynecol Scand. 2022;101:608-615.
    PubMed    
    Abstract available

  289. ERIKSEN DO, Jensen PT, Schroll JB, Hammer A, et al
    Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis.
    Acta Obstet Gynecol Scand. 2022;101:597-607.
    PubMed    
    Abstract available

  290. HANSEN J, Kirkegaard P, Folmann B, Bungum HF, et al
    "I feel reassured, but there is no guarantee." How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study.
    Acta Obstet Gynecol Scand. 2022;101:616-623.
    PubMed    
    Abstract available

  291. BAASLAND I, Vie GA, Romundstad PR, Lonnberg S, et al
    Cervical cancer mortality in Norway according to screening attendance and age.
    Acta Obstet Gynecol Scand. 2022 Jun 11. doi: 10.1111/aogs.14402.
    PubMed    
    Abstract available

  292. HERBST J, Pantel K, Effenberger K, Wikman H, et al
    Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions.
    Br J Cancer. 2022 Jun 20. pii: 10.1038/s41416-022-01868.
    PubMed    
    Abstract available

  293. FENG J, Tang D, Wang J, Zhou Q, et al
    SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, for recurrent or metastatic cervical cancer: a clinical expansion cohort of phase 1 study.
    Clin Cancer Res. 2022 Jun 2. pii: 699316. doi: 10.1158/1078-0432.CCR-22-0346.
    PubMed    
    Abstract available

  294. BRACIC T, Reich O, Taumberger N, Tamussino K, et al
    Does mode of delivery impact the course of cervical dysplasia in pregnancy? A review of 219 cases.
    Eur J Obstet Gynecol Reprod Biol. 2022;274:13-18.
    PubMed    
    Abstract available

  295. PIEDIMONTE S, Pond GR, Plante M, Nelson G, et al
    Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study.
    Gynecol Oncol. 2022 May 26. pii: S0090-8258(22)00310.
    PubMed    
    Abstract available

  296. GENNARI P, Tchaikovski S, Meszaros J, Gerken M, et al
    Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer.
    Gynecol Oncol. 2022 May 23. pii: S0090-8258(22)00313.
    PubMed    
    Abstract available

  297. SCHIFF JP, Mintz R, Cohen AC, Huang Y, et al
    Overall survival in patients with FIGO stage IVA cervical cancer.
    Gynecol Oncol. 2022 Jun 9. pii: S0090-8258(22)00333.
    PubMed    
    Abstract available

  298. ZHOU N, Cui Y, Zhu R, Kuang Y, et al
    Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo.
    Gynecol Oncol. 2022 Jun 7. pii: S0090-8258(22)00306.
    PubMed    
    Abstract available

  299. HORSBOL TA, Kjaer SK, Andersen EW, Ammitzboll G, et al
    Use of hypnotics among women diagnosed with cervical cancer - A population-based cohort study.
    Gynecol Oncol. 2022 Jun 6. pii: S0090-8258(22)00330.
    PubMed    
    Abstract available

  300. SANCHEZ-CUERDA C, Cuadra M, Gamir S, Lobo P, et al
    Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
    Int J Gynaecol Obstet. 2021 Sep 24. doi: 10.1002/ijgo.13948.
    PubMed    
    Abstract available

  301. PFAENDLER KS, Williams HJ
    Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy.
    Int J Gynecol Cancer. 2022;32:815-816.
    PubMed    


  302. WAGNER A, Skof AS, Sehouli J, Richter R, et al
    Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
    Int J Gynecol Cancer. 2022;32:716-723.
    PubMed    
    Abstract available

  303. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
    Importance of conization and pathological status.
    Int J Gynecol Cancer. 2022;32:820.
    PubMed    



  304. Are All Referrals to Colposcopy Clinics Appropriate?: Correction.
    Obstet Gynecol. 2022;139:1198.
    PubMed    


  305. HWANG WY, Chang SJ, Kim HS, Kim NK, et al
    Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators
    BMC Cancer. 2022;22:603.
    PubMed    
    Abstract available

  306. PAN B, Wan T, Jiang Y, Zheng X, et al
    Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer.
    BMC Cancer. 2022;22:655.
    PubMed    
    Abstract available

  307. ZHANG W, Cao H, Yang J, Zhao J, et al
    The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
    BMC Cancer. 2022;22:636.
    PubMed    
    Abstract available

  308. NIE C, Qin H, Zhang L
    Identification and validation of a prognostic signature related to hypoxic tumor microenvironment in cervical cancer.
    PLoS One. 2022;17:e0269462.
    PubMed    
    Abstract available

  309. AMO-ANTWI K, Agambire R, Konney TO, Nguah SB, et al
    Health-related quality of life among cervical cancer survivors at a tertiary hospital in Ghana.
    PLoS One. 2022;17:e0268831.
    PubMed    
    Abstract available

  310. MEBRATIE AE, Moges NA, Meselu BT, Melesse MF, et al
    Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.
    PLoS One. 2022;17:e0269576.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;